|
1
|
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
|
J Clin Oncol
|
2006
|
4.87
|
|
2
|
Retracted
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
|
Lancet Oncol
|
2007
|
3.67
|
|
3
|
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
|
Lancet Oncol
|
2011
|
1.85
|
|
4
|
Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement--Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer.
|
J Clin Oncol
|
2006
|
1.75
|
|
5
|
Rectal cancer surgery with or without bowel preparation: The French GRECCAR III multicenter single-blinded randomized trial.
|
Ann Surg
|
2010
|
1.67
|
|
6
|
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
|
J Clin Oncol
|
2013
|
1.34
|
|
7
|
Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
|
Clin Cancer Res
|
2009
|
1.23
|
|
8
|
MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy.
|
Radiology
|
2012
|
1.18
|
|
9
|
Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.02
|
|
10
|
Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.
|
Oncologist
|
2012
|
0.98
|
|
11
|
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.
|
BMC Cancer
|
2005
|
0.98
|
|
12
|
The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the "DISTANCE"?
|
Radiology
|
2013
|
0.95
|
|
13
|
Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.
|
Gynecol Oncol
|
2011
|
0.92
|
|
14
|
Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy.
|
Breast Cancer Res Treat
|
2002
|
0.92
|
|
15
|
Intra-operative radiotherapy of rectal cancer: results of the French multi-institutional randomized study.
|
Radiother Oncol
|
2011
|
0.92
|
|
16
|
Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.92
|
|
17
|
Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
|
Int J Cancer
|
2012
|
0.89
|
|
18
|
EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancer.
|
Int J Cancer
|
2010
|
0.88
|
|
19
|
Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer.
|
Clin Cancer Res
|
2012
|
0.87
|
|
20
|
Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.
|
Breast
|
2011
|
0.86
|
|
21
|
Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
|
J Magn Reson Imaging
|
2012
|
0.86
|
|
22
|
Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.85
|
|
23
|
Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial.
|
Radiat Oncol
|
2013
|
0.84
|
|
24
|
Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection.
|
Anal Biochem
|
2005
|
0.82
|
|
25
|
Interest of investigating p53 status in breast cancer by four different methods.
|
Oncol Rep
|
2002
|
0.81
|
|
26
|
Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer.
|
Clin Cancer Res
|
2008
|
0.81
|
|
27
|
Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
|
Tumour Biol
|
2003
|
0.80
|
|
28
|
Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration.
|
Eur J Pharm Sci
|
2007
|
0.80
|
|
29
|
Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
|
Lancet Oncol
|
2011
|
0.78
|
|
30
|
Surgery for esophageal cancer after concomitant radiochemotherapy: oncologic and functional results.
|
World J Surg
|
2005
|
0.77
|
|
31
|
Cost of radiofrequency ablation in the treatment of hepatic malignancies.
|
Gastroenterol Clin Biol
|
2007
|
0.76
|
|
32
|
Cost-Effectiveness of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications.
|
Int J Gynecol Cancer
|
2015
|
0.76
|
|
33
|
To Drain or Not to Drain Infraperitoneal Anastomosis After Rectal Excision for Cancer: The GRECCAR 5 Randomized Trial.
|
Ann Surg
|
2017
|
0.76
|
|
34
|
Randomized study of aggressive surgery for advanced ovarian cancer.
|
Int J Gynecol Cancer
|
2013
|
0.75
|
|
35
|
[Locally advanced rectal cancer management: which role for the pathologist in 2011?].
|
Ann Pathol
|
2011
|
0.75
|
|
36
|
[Vascular hepatic injury following neoadjuvant treatment for a cardial adenocarcinoma].
|
Gastroenterol Clin Biol
|
2006
|
0.75
|
|
37
|
[Rectal cancer Information dedicated to cancer patients and relatives].
|
Bull Cancer
|
2006
|
0.75
|
|
38
|
Spontaneous apoptosis in the intra-ductal component's stroma of breast invasive carcinoma.
|
Anticancer Res
|
2004
|
0.75
|
|
39
|
[Positive sentinel node biopsy in breast cancer: is axillary surgery necessary in all cases?].
|
Bull Cancer
|
2007
|
0.75
|
|
40
|
[Recent data on lobular neoplasia of the breast: the pathologist's opinion].
|
Bull Cancer
|
2005
|
0.75
|
|
41
|
[An unusual liver metastasis].
|
Ann Pathol
|
2006
|
0.75
|